Chris LeMasters
Gründer bei Hoosier Oncology Group, Inc.
Profil
Christopher C.
LeMasters was the founder of Cabrellis Pharmaceuticals Corp.
(founded in 2006), Adastra Pharmaceuticals, Inc. (founded in 2007), Aarden Pharmaceuticals, Inc. (founded in 2008), and Hoosier Oncology Group, Inc. (founded in 2009), where he held the titles of Chief Business Officer, Director, and Chief Executive Officer.
He currently holds positions as Chief Executive Officer at XinThera, Inc., Director at January Therapeutics, Inc., and Chief Operating Officer at Amplyx Pharmaceuticals, Inc. He previously held positions as Chief Executive Officer & Director at Promosome LLC, Vice President-Business Development at Conforma Therapeutics Corp., Chief Business Officer & Executive Vice President at Mirati Therapeutics, Inc., and Auditor at Owens Corning.
He also worked as a Consultant at Coopers & Lybrand Consulting, Inc. He received his undergraduate degree from Indiana University in 1988 and his Masters of Business Administration from The University of Chicago in 1994.
Aktive Positionen von Chris LeMasters
| Unternehmen | Position | Beginn |
|---|---|---|
| Hoosier Oncology Group, Inc. | Gründer | 01.10.2009 |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Geschäftsführer | 08.06.2020 |
January Therapeutics, Inc.
 January Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services January Therapeutics, Inc. provides biotechnology services. The company was founded by Robin Jackman and Neil Raheja and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 03.03.2022 |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Vorstandsvorsitzender | 08.09.2022 |
Ehemalige bekannte Positionen von Chris LeMasters
| Unternehmen | Position | Ende |
|---|---|---|
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 03.01.2020 |
Aarden Pharmaceuticals, Inc.
 Aarden Pharmaceuticals, Inc. BiotechnologyHealth Technology Aarden Pharmaceuticals, Inc. operated as a drug discovery and biotechnology company. The company was founded by Thomas M. Estok, Christopher C. LeMasters, Francis Burrows and Zhong-Yin Zhang in 2008 and was headquartered in Indianapolis, GA. | Gründer | 01.05.2016 |
Adastra Pharmaceuticals, Inc.
 Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Adastra Pharmaceuticals, Inc. engages in the provision of clinical and commercial development of proprietary drugs for the treatment of various cancers. The company was founded by Tracy L. Parrott in 2005 and is headquartered in Princeton, NJ. | Gründer | 01.08.2015 |
Cabrellis Pharmaceuticals Corp.
 Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Gründer | 01.12.2007 |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.05.2006 |
Ausbildung von Chris LeMasters
| Indiana University | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| OWENS CORNING | Process Industries |
| Private Unternehmen | 11 |
|---|---|
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Health Technology |
Cabrellis Pharmaceuticals Corp.
Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Health Technology |
Adastra Pharmaceuticals, Inc.
Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Adastra Pharmaceuticals, Inc. engages in the provision of clinical and commercial development of proprietary drugs for the treatment of various cancers. The company was founded by Tracy L. Parrott in 2005 and is headquartered in Princeton, NJ. | Health Technology |
Promosome LLC
 Promosome LLC BiotechnologyHealth Technology Promosome LLC is a biotechnology company specializing in technologies related to the regulation of protein synthesis through translation initiation. Its proprietary mRNA engineering technology exploits features of the natural translation process in both prokaryotic and eukaryotic cells. The technologies involve recoding mRNAs for biotherapeutic agents to enhance ribosome recruitment, eliminate false starts in translation initiation, and ensure message stability in both eukaryotic and prokaryotic cells. Promosome was founded by William J. Gedale and John R. Costantino in 2003 and is headquartered in New York, NY. | Health Technology |
Aarden Pharmaceuticals, Inc.
Aarden Pharmaceuticals, Inc. BiotechnologyHealth Technology Aarden Pharmaceuticals, Inc. operated as a drug discovery and biotechnology company. The company was founded by Thomas M. Estok, Christopher C. LeMasters, Francis Burrows and Zhong-Yin Zhang in 2008 and was headquartered in Indianapolis, GA. | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Health Technology |
| Coopers & Lybrand Consulting, Inc. | |
| Hoosier Oncology Group, Inc. | |
January Therapeutics, Inc.
January Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services January Therapeutics, Inc. provides biotechnology services. The company was founded by Robin Jackman and Neil Raheja and is headquartered in San Diego, CA. | Commercial Services |
Xinthera, Inc.
Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Health Technology |
